Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 29;31(1):3.
doi: 10.1038/s41533-020-00215-7.

Risks of poor asthma outcome in 14,405 children and young people in London

Mark L Levy  1
Affiliations

Risks of poor asthma outcome in 14,405 children and young people in London

Mark L Levy. NPJ Prim Care Respir Med. .

Abstract

This is a 12-month retrospective data analysis (2018/19) of asthma risk factors in 350 North West London general practices. Fourteen thousand four hundred and five of the 482,029 (40% female) children and young people (CYP) had diagnosed asthma. Exacerbations are as follows: (i) 749 (5%) CYP had 797 hospital admissions; 32 (<1%) had 2-6; (ii) 910 (6%) had 1168 recorded asthma attacks; 170 (1%) had 2-12; (iii) 1485 (10%) had 2123 oral corticosteroid courses; 408 (3%) had 2-11. Excess short-acting bronchodilators were prescribed in over half of the CYP. Of the 10,077 (70%) CYP prescribed inhaled corticosteroid preventers, 7279 (72%) were issued with <4 ICS inhaler prescriptions during the year; these CYP accounted for 11% of the admission spells. In all, 30% of CYP had poor symptom control. At least 10% of the CYP having had recent attacks are at risk and dashboards such as those available in North West London could easily facilitate recognition of risk and optimisation of care.

PubMed Disclaimer

Conflict of interest statement

M.L.L. reports personal fees from Teva, Astra Zeneca, Novartis, non-financial support and other from GINA, personal fees from Chiesi, grants from Conzorcio Futuro In Ricerca, personal fees from Soar Beyond, Orion Pharmaceuticals, Menarini pharmaceuticals, Napp Pharmaceuticals, GSK, personal fees from National Services for Health Improvement (a company providing services for general practices (Expert Nurse Reviews)), non-financial support from Asthma and COPD (Joint) Lead for Whole Systems Integrated Care (WSIC) North West London, personal fees from Trudel Pharmaceuticals, outside the submitted work. He is also Editor Emeritus of the npj Primary Care Respiratory Medicine but has no role nor influence in any decisions regarding publication.

References

    1. National Review of Asthma Deaths. Why asthma still kills: the National Review of Asthma Deaths (NRAD) Confidential Enquiry report. http://www.rcplondon.ac.uk/sites/default/files/why-asthma-still-kills-fu... (2014).
    1. Global Initiative for Asthma (GINA). The Global Strategy for Asthma Management and Prevention. http://www.ginasthma.org (2019).
    1. Scottish Intercollegiate Guideline Network (SIGN) & the British Thoracic society (BTS). British guideline on the management of asthma. https://www.sign.ac.uk/sign-158-british-guideline-on-the-management-of-a... (2019).
    1. Levy ML, et al. A review of asthma care in 50 general practices in Bedfordshire, United Kingdom. npj Prim. Care Respir. Med. 2018;28:29. doi: 10.1038/s41533-018-0093-7. - DOI - PMC - PubMed
    1. Shah, R., Hagell, A. & Cheung, R. International comparisons of health and wellbeing in adolescence and early adulthood. https://www.nuffieldtrust.org.uk/files/2019-02/1550657729_nt-ayph-adoles... (2019).

Publication types

Substances